ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

60.51 (USD) • At close September 6, 2024
Bedrijfsnaam ANI Pharmaceuticals, Inc.
Symbool ANIP
Munteenheid USD
Prijs 60.51
Beurswaarde 1,272,531,351
Dividendpercentage 0%
52-weken bereik 48.2 - 70.81
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Nikhil Lalwani
Website https://www.anipharmaceuticals.com

An error occurred while fetching data.

Over ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products,

Vergelijkbare Aandelen

Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc.

CRBU

1.72 USD

Century Therapeutics, Inc. logo

Century Therapeutics, Inc.

IPSC

1.46 USD

Inhibrx, Inc. logo

Inhibrx, Inc.

INBX

15.06 USD

Cullinan Oncology, Inc. logo

Cullinan Oncology, Inc.

CGEM

17.98 USD

Intercept Pharmaceuticals, Inc. logo

Intercept Pharmaceuticals, Inc.

ICPT

19 USD

Nano-X Imaging Ltd. logo

Nano-X Imaging Ltd.

NNOX

5.9 USD

Aura Biosciences, Inc. logo

Aura Biosciences, Inc.

AURA

7.78 USD

Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc.

TNGX

10.89 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)